Found 15 matching trials
The Efficacy and Safety of Sintilimab Plus Chemotherapy in Surgical Conversion for Patients With Unresectable Stage IIIB-IIIC NSCLC: A Prospective, Single-Arm, Phase II Study PHASE2 This study aimed to evaluate the conversion rate to curative-intent treatme...
Show More Location
Multiple Locations
Learn More & Join Trial
A Exploratory Study of Nivolumab Monotherapy or in Combination With Nab-paclitaxel and Carboplatin in Early Stage NSCLC in China PHASE2 Nivolumab (BMS-936558) is a fully human, IgG4 (kappa) isotype mAb that bind...
Show More Status
Active Not Recruiting
Location
Guangdong Lung Cancer Institute, Guangdong General Hospital, Guangdong Academy of Medical Sciences
Learn More & Join Trial
Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA PHASE2 The aim of this study is to test whether adding chemotherapy/cabazitaxel an...
Show More Location
H. Lee Moffitt Cancer Center and Research Institute
Learn More & Join Trial
A Study of Definitive Therapy to Treat Prostate Cancer PHASE2 To assess the safety of treating men with oligometastatic prostate cancer w...
Show More Location
Sibley Memorial Hospital
Learn More & Join Trial
MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA) PHASE2 The purpose of this study is to find out if giving radiation therapy (RT) t...
Show More Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial
Paclitaxel, Cyclophosphamide & Doxorubicin, Autologous Dendritic Cells & Surgery in Stage II/III Breast Cancer (Women) PHASE2 RATIONALE: Drugs used in chemotherapy, such as paclitaxel, cyclophosphamide...
Show More Location
H. Lee Moffitt Cancer Center and Research Institute, University of South Florida
Learn More & Join Trial
Best Salvage Treatment for High-risk Relapsing Prostate Cancer (PEACE-9 - ESCALATE-RT) PHASE3 The goal of this clinical trial is to learn if adding metastasis-directed r...
Show More Learn More & Join Trial
Consolidative Local Therapy (CLT) in Oligo-metastatic Urothelial Carcinoma PHASE2 This study investigates the therapeutic benefit of consolidative local ther...
Show More Learn More & Join Trial
CONVERT-HB1: Radical Prostatectomy After Systemic Therapy for High-volume Metastatic Hormone-sensitive Prostate Cancer PHASE2 This is a prospective, randomized, open-label, phase II multicenter clinica...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Comparing Radical Surgery and Radical Radiotherapy as First Definitive Treatment for Primary MCC NA A randomised phase III multi-centre trial comparing radical surgery and rad...
Show More Location
University Hospital Birmingham NHS Foundation Trust
Learn More & Join Trial